Mingeot-Leclercq M P, Brasseur R, Schanck A
Unité de Pharmacologie Cellulaire et Moléculaire, Université Catholique de Louvain, Brussels, Belgium.
J Toxicol Environ Health. 1995 Mar;44(3):263-300. doi: 10.1080/15287399509531960.
Aminoglycoside antibiotics are hydrophilic molecules consisting of an animated cyclitol associated with amino sugar. They bind in vivo as well as in vitro to negatively charged membranes. Their use as chemotherapeutic agents is unfortunately accompanied by oto- and nephrotoxic reactions, and the purpose of this review is to examine the role of the molecular interactions between aminoglycosides and membranes in the development of nephrotoxicity. 31P Nuclear magnetic resonance (NMR) and fluorescence depolarization have been used to characterize the effect of aminoglycosides on phosphate heads and fatty acyl chains of phospholipids. 15N NMR has been used to obtain interesting information on regioselective interactions of amino groups of antibiotics with phospholipids. The binding of aminoglycosides with negatively charged membranes is associated with impairment of phospholipid catabolism, change in membrane permeability, and membrane aggregation. Biochemical analysis and 1H NMR spectroscopy have brought information on the molecular mechanism involved in the impairment of phospholipid catabolism. Nephrotoxic aminoglycosides could induce sequestration of phosphatidylinositol and therefore reduce the amount of negative charge available for optimal lysosomal phospholipase activity toward phosphatidylcholine included in liposomes that also contain cholesterol and sphingomyelin. Conformational analysis shows that aminoglycosides, which have a high potency to inhibit lysosomal phospholipase activity, adopt an orientation parallel to the lipid/water interface. This orientation of the aminoglycoside molecule at the interface is also critical to explain the marked increase of membrane permeability induced by less nephrotoxic aminoglycosides such as isepamicin and amikacin. This effect is indeed only observed with aminoglycosides oriented perpendicular to this interface, probably related to the creation of a local condition of disorder. The impairment of phospholipid catabolism, which is considered to be an early and significant step in the development of aminoglycoside toxicity, is therefore not related to the change in membrane permeability. However, the role of this latter phenomenon and of membrane aggregation for aminoglycoside nephrotoxicity could be further investigated.
氨基糖苷类抗生素是由一个与氨基糖相连的含氮环醇组成的亲水分子。它们在体内和体外均能与带负电荷的膜结合。不幸的是,它们作为化疗药物使用时会伴有耳毒性和肾毒性反应,本综述的目的是研究氨基糖苷类与膜之间的分子相互作用在肾毒性发展中的作用。31P核磁共振(NMR)和荧光去极化已被用于表征氨基糖苷类对磷脂磷酸头部和脂肪酰链的影响。15N NMR已被用于获取关于抗生素氨基与磷脂区域选择性相互作用的有趣信息。氨基糖苷类与带负电荷的膜结合与磷脂分解代谢受损、膜通透性改变和膜聚集有关。生化分析和1H NMR光谱提供了有关磷脂分解代谢受损所涉及分子机制的信息。具有肾毒性的氨基糖苷类可诱导磷脂酰肌醇的隔离,从而减少可用于对包含胆固醇和鞘磷脂的脂质体中磷脂酰胆碱进行最佳溶酶体磷脂酶活性的负电荷量。构象分析表明,具有高效抑制溶酶体磷脂酶活性的氨基糖苷类采取与脂质/水界面平行的取向。氨基糖苷类分子在界面处的这种取向对于解释由肾毒性较小的氨基糖苷类如异帕米星和阿米卡星引起的膜通透性显著增加也至关重要。实际上,只有当氨基糖苷类垂直于该界面取向时才会观察到这种效应,这可能与局部无序状态的产生有关。因此,磷脂分解代谢受损,这被认为是氨基糖苷类毒性发展中的一个早期且重要的步骤,与膜通透性的变化无关。然而,后一种现象以及膜聚集对氨基糖苷类肾毒性的作用可能需要进一步研究。